Biopolitical Times

The Center for Genetics and Society blog highlights the latest developments in the social, political, and ethical implications of human biotechnologies, with contributions from staff, fellows, consultants, and guest authors.

Subscribe


Petri dish and dropper on green background

In the leadup to the 2024 election, Donald Trump repeatedly promised to make IVF more accessible. He made the commitment central to his campaign, even referring to himself as the “father of IVF.” In his first month in office, Trump issued an executive order promising to expand IVF access. The order set a 90-day deadline for policy recommendations for “lowering costs and reducing barriers to IVF,” although it didn’t make any substantive reproductive healthcare policy changes.

The response to the...

Biopolitical Times

Sir Francis Galton, 1890s, by Eveleen Myers (née Tennant)
npg.org
Public Domain via Wikipedia

As has been discussed in recent issues of Biopolitical Times (1, 2), there are, increasingly, companies that claim to be selling parents better babies by selecting the “best” embryos. These services don’t come cheap – think $50,000, or even more, for embryo testing, plus perhaps as much again for IVF and concomitant services. To most of us, that is extremely expensive...

If you’ve been online or caught the news in the past few weeks, you’ve probably come across Sydney Sweeney, her “great genes jeans,” and much debate over whether they reflect a resurgence of eugenics in American politics and culture.

In...

On July 21, the American Academy for Pediatrics (AAP) released new landmark recommendations for the care of children with trisomy 13 and trisomy 18, in which babies are born with a third copy of chromosome 13 or 18. Historically, trisomy 13...